schémas thérapeutiques à agent unique

Libellé préféré : schémas thérapeutiques à agent unique;

Définition NCIt : Une série de traitements médicamenteux comportant un agent.;

CUI Metathesaurus NCI : CL969844;

Détails

Identifiant d'origine

C160951;

CUI UMLS

C5205681;

Sous-ensemble contenant les concepts
- fluorouracile en perfusion continue [Concept NCIt]
- irinotécan tous les 14 jours [Concept NCIt]
- irinotécan tous les 21 jours [Concept NCIt]
- méthylprednisolone à haute dose [Concept NCIt]
- procole évérolimus [Concept NCIt]
- protocle pémigatinib [Concept NCIt]
- protocole BCG [Concept NCIt]
- protocole BCG intralésionnel [Concept NCIt]
- protocole Erlotinib [Concept NCIt]
- protocole Lénalidomide/Tafasitamab [Concept NCIt]
- protocole abiratérone [Concept NCIt]
- protocole abémaciclib [Concept NCIt]
- protocole acalabrutinib [Concept NCIt]
- protocole acitrétine [Concept NCIt]
- protocole adagrasib [Concept NCIt]
- protocole ado-trastuzumab emtansine [Concept NCIt]
- protocole afatinib [Concept NCIt]
- protocole aldesleukine [Concept NCIt]
- protocole aldesleukine intralésionnelle [Concept NCIt]
- protocole alectinib [Concept NCIt]
- protocole alitrétinoïne topique [Concept NCIt]
- protocole altrétamine [Concept NCIt]
- protocole amivantamab [Concept NCIt]
- protocole anakinra [Concept NCIt]
- protocole anastrozole [Concept NCIt]
- protocole apalutamide [Concept NCIt]
- protocole atézolizumab [Concept NCIt]
- protocole avapritinib [Concept NCIt]
- protocole avélumab [Concept NCIt]
- protocole axitinib [Concept NCIt]
- protocole azacitidine [Concept NCIt]
- protocole belzutifan [Concept NCIt]
- protocole bendamustine [Concept NCIt]
- protocole bexarotène topique [Concept NCIt]
- protocole bicalutamide [Concept NCIt]
- protocole binimétinib [Concept NCIt]
- protocole blinatumomab [Concept NCIt]
- protocole bortézomib [Concept NCIt]
- protocole bosutinib [Concept NCIt]
- protocole brentuximab védotine [Concept NCIt]
- protocole bélinostat [Concept NCIt]
- protocole bévacizumab [Concept NCIt]
- protocole bévacizumab/carmustine [Concept NCIt]
- protocole cabazitaxel [Concept NCIt]
- protocole cabozantinib [Concept NCIt]
- protocole calaspargase pégol [Concept NCIt]
- protocole capmatinib [Concept NCIt]
- protocole capécitabine [Concept NCIt]
- protocole carboplatine [Concept NCIt]
- protocole carfilzomib [Concept NCIt]
- protocole carmustine [Concept NCIt]
- protocole carmustine topique [Concept NCIt]
- protocole carmustine/thiotépa [Concept NCIt]
- protocole chlorambucil [Concept NCIt]
- protocole cisplatine [Concept NCIt]
- protocole cladribine [Concept NCIt]
- protocole copanlisib [Concept NCIt]
- protocole crizotinib [Concept NCIt]
- protocole cyclophosphamide [Concept NCIt]
- protocole cytarabine intrathécale [Concept NCIt]
- protocole cytarabine liposomale-daunorubicine [Concept NCIt]
- protocole cytarabine sous-cutanée [Concept NCIt]
- protocole cytarabine à faible dose [Concept NCIt]
- protocole cytarabine à haute dose [Concept NCIt]
- protocole cémiplimab [Concept NCIt]
- protocole céritinib [Concept NCIt]
- protocole cétuximab [Concept NCIt]
- protocole d'entretien par le lénalidomide [Concept NCIt]
- protocole dabrafénib [Concept NCIt]
- protocole dacarbazine [Concept NCIt]
- protocole dacomitinib [Concept NCIt]
- protocole daratumumab [Concept NCIt]
- protocole darbépoétine [Concept NCIt]
- protocole dasatinib [Concept NCIt]
- protocole docétaxel [Concept NCIt]
- protocole dostarlimab [Concept NCIt]
- protocole doxorubicine [Concept NCIt]
- protocole doxorubicine liposomale [Concept NCIt]
- protocole durvalumab [Concept NCIt]
- protocole duvélisib [Concept NCIt]
- protocole décitabine [Concept NCIt]
- protocole dégarélix [Concept NCIt]
- protocole dénosumab [Concept NCIt]
- protocole elranatamab [Concept NCIt]
- protocole encorafénib [Concept NCIt]
- protocole enfortumab védotine [Concept NCIt]
- protocole entrectinib [Concept NCIt]
- protocole enzalutamide [Concept NCIt]
- protocole erdafitinib [Concept NCIt]
- protocole estradiol [Concept NCIt]
- protocole exémestane [Concept NCIt]
- protocole filgrastim [Concept NCIt]
- protocole fludarabine [Concept NCIt]
- protocole fluorouracil [Concept NCIt]
- protocole fluorouracil topique [Concept NCIt]
- protocole fluoxymestérone [Concept NCIt]
- protocole flutamide [Concept NCIt]
- protocole fulvestrant [Concept NCIt]
- protocole fédratinib [Concept NCIt]
- protocole gemcitabine [Concept NCIt]
- protocole gemtuzumab ozogamicine [Concept NCIt]
- protocole giltéritinib [Concept NCIt]
- protocole goséréline [Concept NCIt]
- protocole géfitinib [Concept NCIt]
- protocole histréline [Concept NCIt]
- protocole hyaluronidase humaine recombinante/pertuzumab/trastuzumab [Concept NCIt]
- protocole hyaluronidase humaine recombinante/trastuzumab [Concept NCIt]
- protocole hydroxycarbamide [Concept NCIt]
- protocole ibrutinib [Concept NCIt]
- protocole idélalisib [Concept NCIt]
- protocole ifosfamide [Concept NCIt]
- protocole imatinib [Concept NCIt]
- protocole imiquimod topique [Concept NCIt]
- protocole immunoglobuline équine anti-thymocytes [Concept NCIt]
- protocole infigratinib [Concept NCIt]
- protocole inotuzumab ozogamicine [Concept NCIt]
- protocole interféron alfa-2b [Concept NCIt]
- protocole interféron alfa-2b intralésionnel [Concept NCIt]
- protocole ipilimumab [Concept NCIt]
- protocole irinotécan [Concept NCIt]
- protocole ivosidénib [Concept NCIt]
- protocole ixabépilone [Concept NCIt]
- protocole ixazomib [Concept NCIt]
- protocole lanréotide [Concept NCIt]
- protocole lapatinib [Concept NCIt]
- protocole larotrectinib [Concept NCIt]
- protocole lenvatinib [Concept NCIt]
- protocole leuproréline [Concept NCIt]
- protocole lomustine [Concept NCIt]
- protocole loncastuximab tésirine [Concept NCIt]
- protocole lorlatinib [Concept NCIt]
- protocole lurbinectédine [Concept NCIt]
- protocole lénalidomide [Concept NCIt]
- protocole létrozole [Concept NCIt]
- protocole melphalan [Concept NCIt]
- protocole midostaurine [Concept NCIt]
- protocole mitomycine [Concept NCIt]
- protocole mitotane [Concept NCIt]
- protocole mobocertinib [Concept NCIt]
- protocole mogamulizumab [Concept NCIt]
- protocole mosunétuzumab [Concept NCIt]
- protocole moxétumomab pasudotox [Concept NCIt]
- protocole mégestrol [Concept NCIt]
- protocole mésilate de leuproréline [Concept NCIt]
- protocole méthotrexate [Concept NCIt]
- protocole méthotrexate haute dose [Concept NCIt]
- protocole méthotrexate intrathécal [Concept NCIt]
- protocole nilotinib [Concept NCIt]
- protocole nilutamide [Concept NCIt]
- protocole niraparib [Concept NCIt]
- protocole nivolumab [Concept NCIt]
- protocole nélarabine [Concept NCIt]
- protocole nératinib [Concept NCIt]
- protocole obinutuzumab [Concept NCIt]
- protocole octréotide [Concept NCIt]
- protocole ofatumumab [Concept NCIt]
- protocole olaparib [Concept NCIt]
- protocole olutasidénib [Concept NCIt]
- protocole omacétaxine [Concept NCIt]
- protocole osimertinib [Concept NCIt]
- protocole oxaliplatine [Concept NCIt]
- protocole paclitaxel [Concept NCIt]
- protocole paclitaxel hebdomadaire [Concept NCIt]
- protocole paclitaxel lié à l'albumine [Concept NCIt]
- protocole pacritinib [Concept NCIt]
- protocole palbociclib [Concept NCIt]
- protocole panitumumab [Concept NCIt]
- protocole pazopanib [Concept NCIt]
- protocole pegfilgrastim [Concept NCIt]
- protocole peginterféron alfa-2a [Concept NCIt]
- protocole peginterféron alfa-2b [Concept NCIt]
- protocole pembrolizumab [Concept NCIt]
- protocole pentostatine [Concept NCIt]
- protocole pirtobrutinib [Concept NCIt]
- protocole polatuzumab védotine [Concept NCIt]
- protocole pomalidomide [Concept NCIt]
- protocole ponatinib [Concept NCIt]
- protocole pralatrexate [Concept NCIt]
- protocole pralsétinib [Concept NCIt]
- protocole pémétrexed [Concept NCIt]
- protocole ramucirumab [Concept NCIt]
- protocole rituximab [Concept NCIt]
- protocole rituximab et hyaluronidase humaine [Concept NCIt]
- protocole romidepsine [Concept NCIt]
- protocole ropeginterféron alfa-2b [Concept NCIt]
- protocole rucaparib [Concept NCIt]
- protocole ruxolitinib [Concept NCIt]
- protocole régorafénib [Concept NCIt]
- protocole rélugolix [Concept NCIt]
- protocole sacituzumab govitécan [Concept NCIt]
- protocole selpercatinib [Concept NCIt]
- protocole siltuximab [Concept NCIt]
- protocole sipuleucel-T [Concept NCIt]
- protocole sonidégib [Concept NCIt]
- protocole sorafénib [Concept NCIt]
- protocole sotorasib [Concept NCIt]
- protocole sunitinib [Concept NCIt]
- protocole sélinexor [Concept NCIt]
- protocole sélumétinib [Concept NCIt]
- protocole tagraxofusp [Concept NCIt]
- protocole talazoparib [Concept NCIt]
- protocole talimogène laherparépvec [Concept NCIt]
- protocole tamoxifène [Concept NCIt]
- protocole tazarotène topique [Concept NCIt]
- protocole tazémétostat [Concept NCIt]
- protocole temsirolimus [Concept NCIt]
- protocole thalidomide [Concept NCIt]
- protocole tipiracil/trifluridine [Concept NCIt]
- protocole tivozanib [Concept NCIt]
- protocole tocilizumab [Concept NCIt]
- protocole topotécan hebdomadaire [Concept NCIt]
- protocole topotécane [Concept NCIt]
- protocole torémifène [Concept NCIt]
- protocole trabectédine [Concept NCIt]
- protocole tramétinib [Concept NCIt]
- protocole trastuzumab [Concept NCIt]
- protocole trastuzumab déruxtécan [Concept NCIt]
- protocole trastuzumab intrathécal [Concept NCIt]
- protocole triamcinolone intralésionnelle [Concept NCIt]
- protocole trioxyde d'arsenic [Concept NCIt]
- protocole triptoréline [Concept NCIt]
- protocole tépotinib [Concept NCIt]
- protocole umbralisib [Concept NCIt]
- protocole valrubicine [Concept NCIt]
- protocole vandétanib [Concept NCIt]
- protocole vinblastine [Concept NCIt]
- protocole vinblastine intralésionnelle [Concept NCIt]
- protocole vincristine [Concept NCIt]
- protocole vincristine liposomale [Concept NCIt]
- protocole vinorelbine [Concept NCIt]
- protocole vismodégib [Concept NCIt]
- protocole vorinostat [Concept NCIt]
- protocole vémurafénib [Concept NCIt]
- protocole vénétoclax [Concept NCIt]
- protocole zanubrutinib [Concept NCIt]
- protocole énasidénib [Concept NCIt]
- protocole épirubicine [Concept NCIt]
- protocole époétine alfa [Concept NCIt]
- protocole éribuline [Concept NCIt]
- protocole étoposide [Concept NCIt]
- protocole étoposide oral [Concept NCIt]
- schéma témozolomide [Concept NCIt]
- topotécan tous les 28 jours [Concept NCIt]
- traitement par alemtuzumab [Concept NCIt]
Type(s) sémantique(s)
- procédure thérapeutique ou préventive [Type sémantique UMLS]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

les recommandations
les documents concernant l'enseignement
les documents destinés aux patients